{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:18:59Z","timestamp":1782371939401,"version":"3.54.5"},"reference-count":41,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2026,6,3]]},"DOI":"10.1080\/14740338.2025.2464896","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:57:53Z","timestamp":1738929473000},"page":"1165-1180","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Adverse drug event profile of pharmacotherapies for alcohol use disorder: a retrospective pharmacovigilance disproportionality analysis study"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3811-6503","authenticated-orcid":false,"given":"Kannan","family":"Sridharan","sequence":"first","affiliation":[{"name":"Arabian Gulf University","place":["Manama, Kingdom of Bahrain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"e_1_3_6_2_1","unstructured":"Alcohol use disorder: a comparison between DSM\u2013IV and DSM\u20135. National institute on alcohol abuse and alcoholism. [cited 2024 Nov 27]. Available from: https:\/\/www.niaaa.nih.gov\/publications\/brochures-and-fact-sheets\/alcohol-use-disorder-comparison-between-dsm"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31775-1"},{"key":"e_1_3_6_4_1","unstructured":"World Health Organization. Over 3 million annual deaths due to alcohol and drug use majority among men. [cited 2024 Aug 1]. Available from: https:\/\/www.who.int\/news\/item\/25-06-2024-over-3-million-annual-deaths-due-to-alcohol-and-drug-use-majority-among-men"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7040099"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.767506"},{"key":"e_1_3_6_7_1","unstructured":"Alcohol\u2019s Effects on Health. Research-based information on drinking and its impact. National institute on alcohol abuse and alcoholism. [cited 2024 Aug 1]. Available from: https:\/\/www.niaaa.nih.gov\/publications\/brochures-and-fact-sheets\/treatment-alcohol-problems-finding-and-getting-help"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00406-1"},{"issue":"1","key":"e_1_3_6_9_1","first-page":"71","article-title":"Medications for alcohol use disorder","volume":"109","author":"Poorman E","year":"2024","unstructured":"Poorman E, McQuade BM, Messmer S. Medications for alcohol use disorder. Am Fam Physician. 2024;109(1):71\u201378.","journal-title":"Am Fam Physician"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1404025"},{"key":"e_1_3_6_11_1","unstructured":"Singh D Saadabadi AN. Updated 2023 May 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534811\/"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15572"},{"key":"e_1_3_6_13_1","volume-title":"(Treatment Improvement Protocol (TIP) Series, No. 49.) Chapter 4\u2014Oral Naltrexone","author":"Center for Substance Abuse Treatment","year":"2009","unstructured":"Center for Substance Abuse Treatment. Incorporating alcohol pharmacotherapies into medical practice. Rockville (MD): substance abuse and mental health services administration (US). In: (Treatment Improvement Protocol (TIP) Series, No. 49.) Chapter 4\u2014Oral Naltrexone. 2009. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK64042\/"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12070"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3934"},{"key":"e_1_3_6_16_1","first-page":"119","volume-title":"Handbook of clinical alcoholism treatment","author":"Ait-Daoud N","year":"2003","unstructured":"Ait-Daoud N, Johnson BA. Medications for the treatment of alcoholism. In: Johnson B, Ruiz P Galanter M, editors. Handbook of clinical alcoholism treatment. Baltimore: Lippincott Williams & Wilkins; 2003. p. 119."},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.1750101"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1242-0"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.4137\/SART.S9345"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-016-0416-y"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-012-0014-6"},{"key":"e_1_3_6_22_1","unstructured":"Questions and answers on FDA\u2019s adverse event reporting system (FAERS). United states food and drug administration. [cited 2024 Jun 9]. Available from: https:\/\/www.fda.gov\/drugs\/surveillance\/questions-and-answers-fdas-adverse-event-reporting-system-faers"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.3163\/1536-5050.95.2.224"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2019.01.006"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1001"},{"key":"e_1_3_6_26_1","unstructured":"USFDA. Good pharmacovigilance practices and pharmacoepidemiologic assessment. 2005 Mar [cited 2024 Jun 1]. Available from: https:\/\/www.fda.gov\/files\/drugs\/published\/Good-Pharmacovigilance-Practices-and-Pharmacoepidemiologic-Assessment-March-2005.pdf"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30866"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.13014"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31042"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13944"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00763.x"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.06.027"},{"key":"e_1_3_6_33_1","unstructured":"LiverTox. Clinical and research information on drug-induced liver injury [internet]. Bethesda (MD): national institute of diabetes and digestive and kidney diseases. Naltrexone. 2012 [cited 2020 Mar 24]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548583\/"},{"key":"e_1_3_6_34_1","unstructured":"Stokes M Patel P Abdijadid SD. [Updated 2024 Mar 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459340\/"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.04.024"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.3934\/Neuroscience.2021021"},{"key":"e_1_3_6_37_1","unstructured":"Mental health issues: alcohol use disorder and common Co-occurring conditions. National institute on alcohol abuse and alcoholism. [cited 2024 Aug 2]. Available from: https:\/\/www.niaaa.nih.gov\/health-professionals-communities\/core-resource-on-alcohol\/mental-health-issues-alcohol-use-disorder-and-common-co-occurring-conditions"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12030524"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1159\/000216130"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.16l01953"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1498204"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.19761"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2025.2464896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:50:06Z","timestamp":1780307406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2025.2464896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,3]]}},"alternative-id":["10.1080\/14740338.2025.2464896"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2025.2464896","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-08-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}